Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

The aim of this study is to examine the effects of treatment with varenicline, a partial agonist at the α4β2 and full agonist at the α7 nicotine acetylcholine receptor, on cognitive impairments in people with schizophrenia. In all, 120 clinically stable people with schizophrenia participated in rand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shim, Joo-Cheol, Jung, Do-Un, Jung, Sung-Soo, Seo, Young-Soo, Cho, Deuk-Man, Lee, Ji-Heon, Lee, Sae-Woom, Kong, Bo-Geum, Kang, Je-Wook, Oh, Min-Kyung, Kim, Sang-Duk, McMahon, Robert P, Kelly, Deanna L
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260973/
https://ncbi.nlm.nih.gov/pubmed/22048460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2011.238
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars